Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P01CA236585
National Institutes of Health
Grant: R21AI156592
Veterans Health Administration
Grant: I01BX003801
National Institutes of Health
Grant: 5P01CA236585-02
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
National Institutes of Health
Grant: 1R21AI156592-01
Targeting YAP with statins to prevent antibody-mediated transplant rejection
National Institutes of Health
Grant: 5I01BX003801-04
Identification of the growth-promoting PKD/YAP axis as a novel target for the statins in intestinal epithelial cells.
FWCI
2.67
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Propofol enhances stem-like properties of glioma via GABAAR‐dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism
Additional file 1 of Propofol enhances stem-like properties of glioma via GABAAR‐dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism
Additional file 2 of Propofol enhances stem-like properties of glioma via GABAAR‐dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism
Additional file 2 of Propofol enhances stem-like properties of glioma via GABAAR‐dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism